Overview Fundamentals API Earnings EOD API Sample Code Pricing

IMMUNITYBIO INC. DL-0001 (26CA F) stock market data APIs

€5.598 0.29(5.5%) as of October 29, 2024
Price chart is built with Anychart

ImmunityBio, Inc., a clinical-stage biotechnology company, engages in developing therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. Its platforms for the development of biologic product candidates include antibody-cytokine fusion proteins; DNA, RNA, and recombinant protein vaccines; and cell therapies. The company's platforms have generated therapeutic agents that are currently being or planned to be studied in clinical trials across various indications in liquid and solid tumors, including bladder, lung and colorectal cancers, and glioblastoma multiforme. Its lead biologic product candidate is Anktiva, an FDA-approved immunotherapy in combination with bacillus calmette-guérin (BCG) for the treatment of adult patients with BCG unresponsive non-muscle invasive bladder cancer with carcinoma in situ, with or without papillary tumors. The company has collaboration agreements with National Cancer Institute. It also has license agreements with 3M Innovative Properties Company; Access to Advanced Health Institute; LadRx Corporation; Sanford Health; Shenzhen Beike Biotechnology Co. Ltd.; Viracta Therapeutics, Inc.; and GlobeImmune, Inc. The company is based in San Diego, California.

IMMUNITYBIO INC. DL-0001 Financial Data Overview

5.312
5.598
-
5.91
5.268
2.56-9.208
4 117 M
697 M
1 308 K
-0.23
-0.346
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '26CA',
Type: 'Common Stock',
Name: 'IMMUNITYBIO INC. DL-0001',
Exchange: 'F',
CurrencyCode: 'EUR',
CurrencyName: 'Euro',
CurrencySymbol: '€',
CountryName: 'Germany',
CountryISO: 'DE',
OpenFigi: NULL,
ISIN: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
CUSIP: NULL,
}

IMMUNITYBIO INC. DL-0001 Fundamental Data is available in our Financial Data APIs

  • Net Revenue 1 308 K
  • EBITDA -341 056 992
  • Earnings Per Share -0.89
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get IMMUNITYBIO INC. DL-0001 Earnings via APIs

  • Latest Release 2021-06-30
  • EPS/Forecast -0.12

Get IMMUNITYBIO INC. DL-0001 End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com